Reccura Therapeutics

Reccura Therapeutics is a pre-clinical stage biotechnology company pioneering the development of small molecule therapeutics that target regulatory RNA structures. The company's proprietary platform is designed to identify and optimize small molecules that bind to RNA G-quadruplexes (G4s), which are structural motifs involved in the translational regulation of key oncogenic drivers. By targeting these RNA structures, Reccura aims to provide a novel therapeutic approach for "undruggable" targets in oncology and other complex diseases. Founded on research from the City of Hope, the company is headquartered in Duarte, California, and is supported by venture capital and institutional partners.